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Abstract 
Background: Clonidine and Dexmedetomidine as an additive to 
Levobupivacaine in ultrasound-guided axillary brachial plexus block are not 
studied well. Hence, this study was designed to compare the efficacy of the 
Clonidine and Dexmedetomidine, used as an adjunct to Levobupivacaine in 
ultrasound-guided axillary brachial plexus block in upper limb elective 
surgery. 
Materials and Methods: Eighty patients of the American Society of 
Anesthesiologists Grade I/II undergoing upper limb elective surgery were 
divided into two equal age/gender-matched groups. Group-LD received 
ultrasound-guided axillary brachial plexus block using injection 0.5% 
Levobupivacaine 20 ml+dexmedetomidine (1 μg/Kg), and group LC received 
ultrasound-guided axillary brachial plexus block using injection 0.5% 
Levobupivacaine 20 ml + Clonidine (1.5 μg/Kg). The onset and duration of 
sensory and motor block, hemodynamics, and side effects were recorded.  
Results: The time for onset of sensory block and motor block in group LD 
was significantly faster than group LC (4.53±1.07 and 7.88±1.29 min vs. 
5.90±0.81 and 8.85±1.81min, p<0.0001). The duration of motor block in 
group LD was significantly longer than group LC (Sensory and motor 
block: 662.50 ± 50.95 and 625.50 ± 51.95min, vs 567.75 ± 62.33 and 
560.62 ± 67.19 min. p< 0.0001). The sedation score was highly significant 
at 30 min (p<0.0001) and was significant at 60 min (p<0.05), 
postoperatively.  
Conclusion: The addition of Dexmedetomidine (1μg/Kg) as an adjuvant to 
Levobupivacaine (0.5%) for upper limb surgeries by axillary brachial plexus 
block had provided the rapid onset of sensory block and motor block and 
enhanced duration of sensory and motor block with arousable sedation 
without any adverse effects compared to clonidine (1.5μg/Kg).  
Keywords: Axillary Brachial Plexus Block, Dexmedetomidine, Levobupivacaine, 
Clonidine 
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Introduction 
Upper limb surgeries below the shoulder joint are 
mostly performed under the brachial plexus block. 
Brachial plexus techniques include interscalene block, 
supraclavicular block, infraclavicular block, and 
axillary block. Brachial Plexus Block provides 
effective intraoperative anesthesia and prolonged 
postoperative analgesia without any side effects for 
upper limb surgeries (1). 
Levobupivacaine is an S (-)- enantiomer of 
racemic bupivacaine. Compared with bupivacaine, it 
produces less vasodilation, less hypotensive episodes, 
less CNS toxicity, less negative inotropic effect, less 
prolongation of QTc interval, and a higher toxicity 
threshold (2). However, it has limiting factors like 
delayed onset, patchy and incomplete analgesia.  
Various studies have investigated several 
adjuvants, including opioids, Alpha -2 agonists like 
Dexmedetomidine and Clonidine, neostigmine, 
hyaluronidase, dexamethasone (2, 3). 
Dexmedetomidine is a potent α-2 adrenoceptor 
agonist and about eight times more selective towards 
the α-2 adrenoceptor than Clonidine. It has been used 
as an adjuvant to local anesthetics to prolong block 
and postoperative analgesia in various peripheral 
blocks (4-6). 
The use of USG guidance for the localization 
of nerve plexus has revolutionized regional anesthesia 
(7).  
Levobupivacaine has a great success rate and 
safety along with a marked reduction of the dose of 
local anesthetics and adjuvants (8). Studies comparing 
Clonidine and Dexmedetomidine are reported for 
brachial plexus block, but a high dose of α-2 agonist 
is associated with side effects include hypotension 
and Bradycardia.  
No studies have so far compared the efficacy 
of Clonidine and Dexmedetomidine as an adjuvant to 
Levobupivacaine in ultrasound-guided axillary 
brachial plexus block in upper limb surgeries.  
Hence, we planned a double-blind prospective 
randomized clinical study at our institute to evaluate 
the comparative efficacy of Dexmedetomidine 
(1µg/kg), and Clonidine (1.5µg/kg) used in 
ultrasound-guided axillary brachial plexus block as 
adjuvants to Levobupivacaine in patients undergoing 
upper limb surgeries. 
Methods 
After the institutional ethics committee's approval and 
signed written informed consent, a randomized, 
double-blind study was done. A prospective, double-
blind, randomized controlled study was conducted on 
80 patients undergoing upper limb surgery with ASA 
grade I or II under ultrasound-guided axial, brachial 
plexus block. We have selected fractures of the 
radius, Fracture of the ulna, and both bone fractures 
of the forearm. Surgeries lasted for 2-4 hours. 
Patients who underwent elective upper limb 
surgery posting to the anesthesia department during 
the study period and who satisfied the inclusion 
criteria were selected for the study.  
The sample size was calculated by the 
formula: N = z12 1-α/2p(1-p) d 
Where, p=expected proportion; d=absolute 
precision; 1-α/2=desired confidence level; P=0.6; 
Preci d=10; 1-α/2=95. Required sample size (N)=80. 
Eighty patients were randomly divided into 
two groups using the “slip in the box technique” each 
containing 40 patients (using a computer-generated 
randomization table). 
The study was conducted between the duration 
of January 2019 to June 2020.  
Group LC: (n=40) receive 20ml of 0.5 % of 
Levobupivacaine +1.5 µg/kg of Clonidine. 
Group LD: (n=40) receive 20ml of 0.5 % of 
Levobupivacaine + 1µg/kg of Dexmedetomidine. 
Inclusion criteria were ASA Class I and II of 
age between 20 and 60 years, SBP - 100-140 mm of 
Hg, and DBP - 60-90 mm of Hg. 
Exclusion criteria were ASA Class III and IV, 
Patients with complications like severe anemia, 
severe hypovolemia, shock, septicemia, Abnormal 
CT, BT, or anticoagulant therapy, Local infection at 
the site of axillary block, history of drug allergy to 
local anesthetics, Clonidine, or Dexmedetomidine, 
and the patient refusal.  
Method: The technique, ultrasound-guided 
axillary brachial plexus, was conducted in the 
operation theatre. Investigations include Hb% 
estimation, TC, DC, Urine examination - Albumin, 
Sugar, and Microscopy, X-ray chest, RBS, Blood 
urea, Serum Creatinine, B.T, C.T, PT, aPTT, INR, 
E.C.G, HIV, and HBsAg.  
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Performance of Axillary Block under Ultrasound 
Guidance: Patients were given alprazolam 0.5 mg a 
day before surgery. No sedative premedication on the 
day of surgery was given to avoid interference in 
scoring sedation. 
The patient was placed in the supine position 
with the head turned away from the side of the block. 
The arm is abducted at 900, and the elbow flexed to 
900. The axilla is prepared aseptically. We have used 
High-frequency, linear probes (13-6MHz) for imaging 
because the nerves are superficial (1 to 2 cm) below 
the skin. The most proximal location at the apex of 
the axilla may be the best for viewing all of the 
terminal branches of the brachial plexus. The probe is 
positioned perpendicular to the anterior axillary fold 
and in cross-section to the humerus at the bicipital 
sulcus (and at the level of the axillary pulse) to 
capture the transverse, or short-axis, given the 
neurovascular bundle.  
A 5-cm, 22-gauge insulated needle is used. In-
plane approaches are used for axillary blocks based 
on convenience. The in-plane method involves 
inserting the needle at an acute angle (20 to 30 
degrees) to the skin in a lateral-to-medial direction. 
Typically, the block needle is advanced to the 
direction median nerve. It is then crossed over the 
axillary artery to the ulnar nerve superficially and 
finally behind the artery to the deeper radial nerve. 
The musculocutaneous nerve is usually blocked 
within the coracobrachialis, where its flat shape gives 
a large amount of surface area for a rapid block of 
both sensory and motor fibers after positioning the 
probe, the infiltration of LA distal to the probe 
subcutaneously is recommended to cover the injection 
site and also to block the intercostobrachial nerve. 
After carefully positioning the needle tip, gentle 
negative aspiration is done, and small aliquots of 4-5 
ml of LA are injected around each nerve. All four 
nerves are blocked individually. 
All patients were monitored for onset and 
duration of motor and sensory block and duration of 
analgesia up to 12hrs postoperatively. Sensory 
blockade was tested using the pinprick method along 
with the distribution of the four nerves. 
 
Sensory block graded as follows: Grade-0: sharp pin 
felt, Grade-1: analgesia, dull sensation, Grade-2: 
anesthesia, no sensation. 
Sensory block was assessed corresponding to 
the median nerve, radial nerve, ulnar nerve, and 
musculocutaneous nerve dermatomal areas. Sensory 
onset is considered when there is a dull sensation to 
pinprick (grade-1). The sensory block duration is the 
time interval between the end of LA administration 
and the complete resolution of the anesthesia on the 
dermatomal areas corresponding to all nerves. 
Motor blockade assessment was done using the 
Modified Bromage Scale (MBS) for upper extremities 
on a three-point scale. 
Grade 0= normal motor function with the full 
extension of the elbow, wrist, and fingers.  
Grade1= the ability to move fingers and/or 
wrist only, decrease motor strength;  
Grade 2=complete motor blockade with the 
inability to move fingers. 
The onset of motor blockade was considered 
when there is a grade1 motor blockade. Peak motor 
block was considered if there is a grade 2 motor 
blockade. The motor block duration is the time 
interval between the end of LA administration and the 
recovery of complete motor function. When the block 
is complete patient did not require any rescue 
analgesic intraoperatively. 
The block was considered incomplete when 
any of the segments supplied by the median, radial, 
ulnar and musculocutaneous nerve did not have 
analgesia even after 30 min of drug injection. These 
patients were supplemented with intravenous fentanyl 
(1 μg/ kg) and midazolam (0.02 mg/kg). 
After local anesthetic injection, the onset, 
duration of motor and sensory blockade 
measurements, and vital parameters (pulse, BP, 
SPO2) were carried out 0 min, 5min, 15min, 30 
min,60min,120 360 min 720 min. Postoperatively, the 
patient's motor and sensory blockade and vitals were 
noted half hourly till the block completely wears off. 
Adverse effects like hypotension (i.e., 20% decrease 
relative to baseline), bradycardia (HR < 50 
beats/min), nausea, vomiting, and hypoxemia 
(SPO2<90) if occurred were noted and attended. The 
time between the complete sensory block and the first 
analgesic request was recorded as the duration of 
analgesia (DOA). The pain was assessed using a 
visual analog scale (VAS) 0-10 at an interval of every 
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30 min. The first dose of postoperative analgesia was 
based on VAS≥2 or on-demand made by the patient 
(whichever was early) and was noted for use as 
Analgesia time. The sedation score was assessed 
using a 5-point sedation scale. The scoring was 
recorded as follows: 
Awake and alert [1], sedated but responding to 
verbal stimulus [2], sedated, responding to mild 
physical stimulus [3], sedated, responding to 
moderate or strong physical stimulus [4], and not 
arousable [5]. 
To detect a difference of 179 mins in the 
duration of motor and sensory block, with 80% power 
and 5% level of significance, a sample size of 40 per 
group was chosen(9). Data were analyzed using SPSS 
version 24 for Windows (IBM Corp., Armonk, NY, 
USA). Categorical data were represented as 
frequencies and proportions. Continuous data were 
represented as mean and SD. A χ2 -square test was 
used to find the significance of association for 
qualitative data. The Independent t-test was used as 
the significance test to identify the mean difference 
between the two groups. A paired t-test was the test 
for paired data such as before and after surgery. p-
value <0.05 was considered significance. 
 
Results 
A total of 80 ASA class I and II patients of both 
genders, aged between 18-60 years, posted for upper 
limb surgeries under axillary brachial plexus block 
were selected for the study.  
In group LC, 75.00% of the patients and in 
group LD, 72.50% of the patients were ASA class I, 
whereas 25.00% of patients in group LC and 27.50% 
of patients in group LD were ASA class II (Table 1). 
The distribution of subjects based on ASA class was 
comparable. And no significant difference was 
observed between the groups, as the p-value was 
more than 0.05. The mean duration of onset of 
sensory block in group LD was significantly faster 
than group LC (p< 0.0001). The mean duration of 
motor block onset in the LD group was significantly 
faster than group LC (p<0.05). The mean duration of 
the group LD's sensory block was significantly longer 
than group LC (p< 0.0001). The mean duration of 
motor block in the LD group was significantly longer 
than group LC (p< 0.0001) (Table 1). 
 
Sedation score: At sedation was observed between 
30 min and 60 min from the time of drug injection in 
these two groups. At 15 min, 22.50% of patients in 
group LC are sedated (sedation score 2), whereas, in 
group LD, 27.50% of patients were sedated (sedation 
score 2). The difference in sedation score at 15 min 
was not statistically significant though few subjects in 
both the groups were sedated (p=0.06). At 30 min, in 
group LC, 37.50% of patients were sedated (with 
sedation score 2), whereas 80.00% of patients were 
sedated (65.00% of patients with sedation score 2 and 
15.00% of patients with sedation score 3) in group LD 
which is statistically highly significant (p=0.0001). At 
60 min, in group LC, 47.50% of patients were sedated 
(37.50% of patients with sedation score 2 and 10.00% 
of patients with sedation score 3), and in group LD, 
80.00% of patients were sedated (65.00% of patients 
with sedation score 2 and 15.00% of patients with 
Sedation score 3) which is statistically significant 
(p=0.01). None of the patients had a sedation score of 
4 and above during the study. χ2-square analysis 
showed that the difference in sedation score was 
significant (p<0.05) at 30 and 60 min (Table 2). 
 
Hemodynamics: There were no significant 
differences in the Pulse Rate between the groups 
measured at 0, 5, 15, 30, 60, 120, 360, and 720 mins 
(p>0.05) (Table 3). There were no significant 
differences in the systolic BP between the groups 
measured at 0, 5, 15, 30, 60, 120, 360, and 720 mins 
(p>0.05) (Table 3). There were no significant 
differences in the Diastolic BP between the groups 
measured at 0, 5, 15, 30, 60, 120, 360, and 720 mins 
(p>0.05) (Table3). There were no significant 
differences in the Oxygen saturation between the 
groups measured at 0, 5, 15, 30, 60, 120, 360, and 720 
mins (p>0.05) (Table 3). 
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Discussion 
Ultrasound guidance has established its effectiveness 
and safety and revolutionized the practice of 
peripheral nerve blocks. USG helped us visualize the 
nerve roots and depositing the drug at the plexus (10, 
11). Local anesthetics alone for brachial plexus block 
provide good operative conditions but have a shorter 
postoperative analgesia duration. Various studies used 
different types of local anesthetics such as 
bupivacaine, Levobupivacaine, ropivacaine, 
lignocaine. Chakraborty et al.(11) demonstrated the 
effect of Clonidine as an adjuvant in 0.5% 25 ml of 
bupivacaine-induced supraclavicular brachial plexus 
block. Esmaoglu et al. (12) studied the effect of 
mixing Dexmedetomidine to 0.5% 45 ml of 
Levobupivacaine for axillary brachial plexus 
blockade. Dexmedetomidine has been advised to use 
as an additive to local anesthetic for brachial plexus 
block from 1 μg/kg to 100 μg in adults (13, 14). As 
our study involved USG axial approach to brachial 
plexus block, 1 μg/kg of Dexmedetomidine was used 
as an adjuvant with 20 ml of 0.5% of 
Levobupivacaine.  
Kaur et al. showed a decrease in the onset time 
of motor and sensory block and lower VAS pain 
scores with the administration of Dexmedetomidine 
as an adjuvant to Levobupivacaine in supraclavicular 
brachial plexus block (15).  
Kataria A.P et al. in their study on brachial 
block comprising patients of age ranging from 2.6 to 
90 years. However, in our study, we included patients 
of age group >20 years (16). 
In our study, the mean onset sensory block 
duration in group LC was 5.90 ±0.81 min, and in 
group LD was 4.53±1.07min. The mean onset motor 
block duration in group LC was 8.85±1.81min, and in 
the group, LD was 7.88±1.29 min. Our study showed 
that the onset time of sensory and motor was 
significantly faster in group LD. Similarly, in a survey 
by Manjunatha C, et al., the onset time of sensory and 
motor block was shorter in Group D than in Group C, 
which was significant (P<0.05) (17). Our results 
concur with Agarwal et al. and Ammar and Mahmoud 
(13, 14). 
However, there are wide variations observed in 
the onset sensory and motor block durations in 
different studies. These variations may be due to the 
usage of other types of local anesthetics, their 
concentration and volumes, the dose of 
Dexmedetomidine, and the nature of blocks. 
Agarwal et al. used Dexmedetomidine 100 μg or 1 ml 
saline with 30 ml of 0.325% bupivacaine for a 
supraclavicular block. Ammar and Mahmoud 
compared bupivacaine 0.33% with dexmedetomidine 
0.75μg/kg for infraclavicular  
Table 1: The demographics, surgical characteristics, comparison of Onset of sensory and motor block and sensory 
and motor block duration between two groups. 
Variable Group LC Group LD P-value  
Age [years]  36.40±12.56years 39.10±13.37years >0.05 
Sex [M:F] 28: 12 32: 8 >0.05 
Weight [kgs] 55.72±0.164 57.00±2.98 0.164 
ASA [I:II] 30: 10 29: 11 >0.05 
onset of sensory block (min) 5.90±0.81a 4.53±1.07a <0.0001** 
onset of motor block (min) 8.85±1.81a 7.88±1.29a 0.05 
Duration of sensory block (min) 567.75±62.33a 662.50±50.95a <0.0001** 
Duration of motor block 560.62±67.19a 625.50±51.95a <0.0001** 
aStudent’s unpaired t-test;  P value<0.05: significant; P value<0.001- highly significant.  
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Table 2: Comparison of Sedation score between two groups. 
Time of assessment Score Group LC (%) Group LD (%) χ2 value, Significance 
 
0 min 
1 40 (100%) 40 (100%)  
No Difference 2 0 (0.00%) 0 (0.00%) 
3 0 (0.00%) 0 (0.00%) 
 
5 min 
1 40 (100%) 40 (100%)  
No Difference 2 0 (0.00%) 0 (0.00%) 
3 0 (0.00%) 0 (0.00%) 
 
15 min 
1 31 (77.50%) 29 (72.50%)  
χ2 =0.2667, p=0.60 2 9 (22.50%) 11 (27.50%) 
3 0 (0.00%) 0 (0.00%) 
 
0 min 
1 25 (62.50%) 8 (20.00%) χ2 =17.71, 
p = 0.0001, 
Highly Significant 
2 15 (37.50%) 26 (65.00%) 
3 0 (0.00%) 6 (15.00%) 
 
60 min 
1 21 (52.50%) 8 (20.00%) χ2 =9.179, 
P =0.01, 
significant 
2 15 (37.50%) 26 (65.00%) 
3 4 (10.00%) 6 (15.00%) 
 
120 min 
1 40 (100%) 40 (100%)  
No difference 2 0 (0.00%) 0 (0.00%) 
3 0 (0.00%) 0 (0.00%) 
 
360 min 
1 40 (100%) 40 (100%)  
No difference 2 0 (0.00%) 0 (0.00%) 
3 0 (0.00%) 0 (0.00%) 
 
720 min 
1 40 (100%) 40 (100%)  
No Difference 2 0 (0.00%) 0 (0.00%) 
3 0 (0.00%) 0 (0.00%) 
χ2 test     
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Table 3: Comparison of Systolic, Diastolic blood pressure (mm of Hg), Oxygen saturation (SpO2 percentage), and Pulse 
Rate (beats/min) between the two groups. 
Time of assessment Mean ± SD Mean Difference t* Value p-value 
Group LC Group LD 
Systolic blood pressure      
0 min 120.20±6.77 119.40±6.65 0.800 0.59  
5 min 119.50±7.02 116.90±6.33 2.625 0.08  
15 min 120.00±5.78 117.78±5.03 2.225 0.07  
30 min 117.85±5.92 117.52±5.32 0.325 0.79  
60 min 117.80±6.27 118.70±5.77 0.900 0.50  
120 min 119.15±6.82 118.45±6.69 0.700 0.64  
360 min 117.07±5.58 117.70±5.42 0.625 0.61  
720 min 116.85±17.96 119.15±5.06 2.300 0.43  
Diastolic blood pressure     
0 min 79.35±6.06 78.75±5.83 0.50 0.39 0.06 
5 min 79.41±6.25 78.31±6.23 1.10 0.83 0.072 
15 min 79.26±6.66 79.66±6.65 0.40 0.26 0.08 
30 min 80.55±6.83 77.85±6.69 2.700 1.785 0.07 
60 min 79.11±5.91 79.51±6.43 0.40 0.29 0.065 
120 min 79.56±7.31 79.66±7.08 0.10 0.06 0.62 
360 min 82.15±5.78 80.10±6.04 2.050 1.549 0.12 
720 min 80.75±7.01 79.30±6.71 1.450 0.944 0.34 
Oxygen saturation      
0 min 99.03±0.78 98.81±0.85 0.22 1.26 0.07 
5 min 98.96±0.91 98.89±0.63 0.07 0.41 0.06 
15 min 99.15±0.92 99.00±0.90 0.150 0.70 0.46 
30 min 99.12±0.91 98.87±0.93 0.250 0.14 0.23 
60 min 98.97±0.90 98.77±0.80 0.20 1.16 0.07 
Kumar et al.                                  A Comparative Study of Clonidine and Dexmedetomidine with 0.5% Levobupivacaine    
 Journal of Cellular & Molecular Anesthesia (JCMA) 
256 
120 min 99.37±0.83 99.10±0.54 0.275 1.740 0.08 
360 min 98.90±0.84 98.83±0.61 0.07 0.43 0.08 
720 min 99.03±0.78 98.92±0.75 0.10 0.56 0.063 
Pulse Rate       
0 min 82.52±6.46 83.25±5.96 0.725 0.521 0.60 
5 min 83.12±6.55 82.45±5.98 0.675 0.481 0.63 
15 min 79.92±7.05 78.80±6.58 1.125 0.737 0.46 
30 min 76.10±6.58 73.62±6.20 2.475 1.731 0.08 
60 min 74.20±6.35 73.30±5.62 0.88 0.58 0.555 
120 min 69.82±4.38 68.67±5.73 1.15 1.07 0.28 
360 min 70.37±4.48 71.00±4.23 0.63 -1.54 0.12 
720 min 76.85±5.48 74.75±5.03 2.100 1.783 0.07 
*Students t-test, p <0.05: significant 
 
brachial plexus block against plain bupivacaine. 
Another study reported that Dexmedetomidine 
as an adjuvant to Levobupivacaine is statistically 
highly significant in the onset of sensory and motor 
block than Clonidine as an adjuvant (p<0.001) (18). 
One research reported that Clonidine and 
Dexmedetomidine's analgesic efficacy for USG-
guided supraclavicular brachial plexus block along 
with Levobupivacaine. The sensory and motor 
blockade onset time was significantly earlier in the 
dexmedetomidine group (3.58 ± 0.61 min. and 7.13 ± 
0.89 min.) in comparison to the clonidine group (6.88 
± 0.59 min. and 8.75±0.77 min.). The mean Onset of 
the sensory blockade and motor blockade was faster 
in group D in comparison to group C (P <0.001) (19). 
The statistical analysis showed that the sensory 
and motor block duration in group LD was 
significantly longer than in group LC (p< 0.0001). 
Similar results were found in other similar studies 
(19-21). 
Hosali et al. (2015) also concluded that 
Dexmedetomidine's addition to Levobupivacaine 
significantly prolonged sensory block and motor 
block duration than Clonidine. Karthik et al. also 
(2015) also found that sensory and motor blockade 
was prolonged by adding Dexmedetomidine to 
Levobupivacaine  
In our study, the duration of sensory and motor 
block was 567.75 ± 62.33 and 560.62 ± 67.19 min, 
respectively, in group LC, whereas they were 662.50 
± 50.95, and 625.50 ± 51.95min, respectively, in 
group LD. Our results concur with the study of 
Manjunatha et al. (17).  
Manjunatha et al. reported that the duration of 
sensory and motor block was prolonged (863.8 ± 
106.8 min and 758. 5 ± 121.6 min) in Group D 
compared to Group C (335.6 ± 58.6 min and 308.4 ± 
71.8 min) (p<0.05).  
In group LC, the mean pulse rate ranged from 
69.82±4.90 to 83.12±6.55beats/min. In group LD, the 
mean pulse rate ranged from 68.67±5.73 to 
83.25±5.96beats/min. In group LC, the mean systolic 
blood pressure ranged from 116.85±17.96 to 
120.20±6.77 mm of Hg, whereas in group LD, the 
mean systolic blood pressure ranged from 
116.90±6.33 to 119.40±6.65 mm of Hg. In group LC, 
the mean diastolic blood pressure ranged from 
80.55±6.83 to 83.12±7.31 mm of Hg, whereas in 
group LD, the mean diastolic blood pressure ranged 
from 77.85±6.69 to 80.10±6.04 mm of Hg.  
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Vinod Hosalli et al. conduct the study using 
Dexmedetomidine and Clonidine as adjuvants with 1 
μg/kg each with Levobupivacaine in the axillary 
brachial plexus block. In Group LD, a significantly 
lower pulse rate was observed at 60, 90, and 120 min, 
compared with Group LC, but not less than 60 
beats/min (P<0.001). In Group D, systolic and 
diastolic blood pressure was significantly lower than 
the baseline from 30 to 120 min compared with 
Group C (P<0.001). 
There was a slight decrease in pulse rate in our 
study, 30 min,60 min, 120 min in the 
dexmedetomidine group (P >0.05). In our study, the 
statistical analysis showed no significant difference in 
systolic and diastolic blood pressure between the two 
groups (p>0.05)—similar results seen by Gopal 
Krishan et al.  
Esmaoglu et al. observed Bradycardia in their 
patient group in which 100 mcg of Dexmedetomidine 
was used with Levobupivacaine. In our study slight 
decrease in pulse rate in group Dexmedetomidine 
(P>0.05). The statistical analysis showed no 
significant difference in systolic and diastolic blood 
pressure between the two groups (p>0.05).  
In our study, no patients had a sedation score 
of >4. Nevertheless, when compared to Clonidine, 
Dexmedetomidine showed greater arousable sedative 
effects with a sedation score of 3 was seen. Chi-
square analysis showed that the difference in sedation 
score was highly significant (p<0.0001) at 30 min and 
60 min. No side effects in our study due to the low 
dose of Dexmedetomidine (1mcg/kg). Atul Dixit et al. 
no patients had a sedation score of 3 and above. Chi-
square analysis showed that the difference in sedation 
score was significant (P < 0.05) (22). 
In our study, no patients had any hemodynamic 
disturbances, Bradycardia, or Severe hypotension in 
either study group. None of the patients experienced 
any severe complications such as large hematoma, 
prolonged nerve paralysis, nausea, vomiting, or dry 
mouth, due to the blocking technique at doses 
1.5μg/kg of clonidine and dexmedetomidine 
(1mcg/kg). No other side effects such as nausea, 
vomiting, local anesthetic toxicity, hematoma, and 
respiratory depression were found in either of the 
groups. In contrast, a study by Manjunatha et al. 
demonstrated that two patients who had Bradycardia 
in Group D were treated with injection atropine-i.v. 
HR and blood pressure were lower in Group D. The 
decreased blood pressure is due to inhibition of 
central sympathetic outflow. The presynaptic α-2 
receptors are also stimulated by Dexmedetomidine, 
thereby decreasing norepinephrine release and 
causing a fall in blood pressure and heart rate (23,24). 
Esmaoglu et al. reported the incidence of 
Bradycardia. In the study of Aggarwal et al. and 
Kaygusuz et al., Dexmedetomidine provided better 
hemodynamic stability (25). 
In conclusion, dexmedetomidine (1μg/kg) has 
a superior clinical profile as an adjuvant to 
Levobupivacaine (0.5%) in contrast to Clonidine 
(1.5μg/kg) in the block of brachial plexus axillary due 
to Rapid onset time of sensory and motor block, 
prolonged duration of sensory and motor block, and 




We conclude that the addition of Dexmedetomidine 
(1μg/kg) as an adjuvant to 0.5% levobupivacaine for 
upper extremity surgeries under ultrasound-guided 
axillary brachial plexus block provided the rapid 
onset of sensory block and motor block and 
enhancement of duration of sensory and motor block 
with arousable sedation compared to Clonidine 
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